• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
A.M. Castle & Co.
Ampd Ventures Inc
Brascan Gold Inc
Limelight Networks, Inc. - Common Stock
ProShares Ultra SpaceX
Shanghai
Steel Dynamics, Inc. - Common Stock
Synthesis Energy Systems, Inc. - Common Stock
Vireo Growth Inc
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

EyePoint, Inc. - Common Stock (NQ:EYPT)

0.4281 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 58,082
Open 0.4281
Bid (Size) 0.4254 (100)
Ask (Size) 0.4273 (1,000)
Prev. Close 0.4281
Today's Range 0.4281 - 0.4281
52wk Range 0.3860 - 19.11
Shares Outstanding 34,984,044
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving EyePoint Pharmaceuticals (EYPT)
October 22, 2026
DURAVYU’s Phase 3 LUCIA trial missed its primary endpoint and EYPT shares lost nearly 80% of their value in a single session. Levi & Korsinsky is investigating on behalf of shareholders who may have... 
From Levi & Korsinsky, LLP
Via GlobeNewswire
Unusual Volume Stocks: PRSO, SHFS, AHT Lead Today's Session ↗
October 21, 2026
Via Chartmill

Performance

52-Week Range 97.8% below 52-week high
0.4281
0.3952W Low 19.1152W High
1 Week 86.4% below 1-week high
0.391W Low 3.151W High

EyePoint, Inc. - Common Stock (EYPT) traded between $0.39 and $19.11 over the past 52 weeks and last traded at $0.43, 97.8% below its 52-week high. Over the past week it ranged between $0.39 and $3.15.

Past 12 Months
-85.7%
-89.5%
-96.6%
-96.9%
-97.6%
-96.3%
1W -$2.56
1M -$3.64
3M -$12.04
6M -$13.41
YTD -$17.05
1Y -$11.02

EYPT was -96.3% over the past year, -96.9% over six months, -97.6% year to date, -85.7% in the last week.

12 Months vs Market
EYPT
-96.3%
DIA
+13.3%
SPY
+14.4%
QQQ
+16.3%
IWM
+13.7%

Over the past 12 months EYPT returned -96.3% versus DIA (Dow) +13.3%, SPY (S&P 500) +14.4%, QQQ (Nasdaq 100) +16.3% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 0.01× 3-mo avg
Today 58,082 3-mo avg 8.2M
1W
56.4M
1M
14.4M
3M
8.2M
6M
4.8M
YTD
3.5M
1Y
3.0M

EYPT most recently traded 58,082 shares against a 3-month average daily volume of 8.2M.

More News

Read More
News headline image
EYPT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into EyePoint Pharmaceuticals (EYPT)
October 21, 2026
From Levi & Korsinsky, LLP
Via ACCESS Newswire
Most Active Stocks: SAFX, WFF and EYPT in Heavy-Volume Session ↗
October 19, 2026
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
October 06, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
September 29, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
September 22, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
September 15, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Investigation Launched Into EyePoint, Inc., EYPT Investors are Encouraged to Contact KTMC Law Firm
September 09, 2026
Via NewMediaWire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
September 08, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTIGATION ALERT: Investigation Launched Into EyePoint, Inc. (EYPT), Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP
September 08, 2026
Via NewMediaWire
News headline image
EYEPOINT STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating EyePoint, Inc. on Behalf of EyePoint Stockholders and Encourages Investors to Contact the Firm
September 02, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
EYPT ALERT: Investigation Launched Into EyePoint, Inc., Investors are Encouraged to Contact KTMC Law Firm
September 02, 2026
Via NewMediaWire
News headline image
EYPT SHAREHOLDER ALERT: EyePoint Pharmaceuticals Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
September 01, 2026
From Kirby McInerney LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
September 01, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Kessler Topaz Meltzer & Check, LLP Encourages EyePoint, Inc. (NASDAQ: EYPT) Investors to Contact the Firm
September 01, 2026
Via NewMediaWire
News headline image
NASDAQ: EYPT: Kessler Topaz Meltzer & Check, LLP Launches Investigation Into EyePoint, Inc.
August 31, 2026
Via NewMediaWire
News headline image
EYPT Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages EYPT Investors With Losses to Contact the Firm
August 29, 2026
Via NewMediaWire
News headline image
EYPT Investors Have Opportunity to Join EyePoint, Inc. Fraud Investigation with SBS Law
August 28, 2026
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
NASDAQ: EYPT Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages EyePoint, Inc. (NASDAQ: EYPT) Investors to Contact the Firm
August 26, 2026
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
August 25, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
EYPT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into EyePoint Pharmaceuticals (EYPT)
August 21, 2026
From Levi & Korsinsky, LLP
Via Business Wire
Let's take a look at the stocks that are in motion in today's session. ↗
August 17, 2026
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
August 17, 2026
Via Chartmill
News headline image
EyePoint’s DURAVYU Misses Primary Endpoint in Phase III Wet AMD Trial ↗
August 17, 2026
Via MarketBeat

Frequently Asked Questions

Is EyePoint, Inc. - Common Stock publicly traded?
Yes, EyePoint, Inc. - Common Stock is publicly traded.
What exchange does EyePoint, Inc. - Common Stock trade on?
EyePoint, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for EyePoint, Inc. - Common Stock?
The ticker symbol for EyePoint, Inc. - Common Stock is EYPT on the Nasdaq Stock Market
What is the current price of EyePoint, Inc. - Common Stock?
The current price of EyePoint, Inc. - Common Stock is 0.4281
When was EyePoint, Inc. - Common Stock last traded?
The last trade of EyePoint, Inc. - Common Stock was at 10/22/26 04:00 PM ET
What is the market capitalization of EyePoint, Inc. - Common Stock?
The market capitalization of EyePoint, Inc. - Common Stock is 14.98M
How many shares of EyePoint, Inc. - Common Stock are outstanding?
EyePoint, Inc. - Common Stock has 15M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap